drugset / Trial / NCT04161768
Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Timeline
- Start
- 2018-12-01
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itopride | Small molecule | 50 mg | — |
| Background | Norfloxacin | Small molecule | 400 mg | — |